Status: Not yet recruiting
An Open Label Trial to Evaluate Efficacy and Safety of Roflumilast 0.3% Cream for Chronic Plaque and Nail Psoriasis
This is an open label trial in subjects ≥12 years of age and older with chronic plaque psoriasis and moderate to severe nail psoriasis. Eligible participants will apply roflumilast 0.3% cream daily for 24 weeks to affected nails daily for the entire study duration and to psoriasis plaques daily until clear.
Participants needed: 15
Trial details
Phase: Phase 4Biological sex: AllType: InterventionalSponsor: Modern Research Associates, PLLCUpdated: Jul 28, 2026Locations: 1
Eligibility criteria
Participants legally competent to sign and give informed consent. [+11]
Subjects who cannot discontinue medication and treatments prior to the Baseline... [+23]